Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

The US Food and Drug Administration (FDA) has expanded the approval for Johnson & Johnson’s nasal spray Spravato to allow its standalone use in patients with depression, the company said on Jan 21.

The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

SINGAPORE (The Straits Times/ANN): Ketamine, the controlled drug best known as a horse tranquilliser or party supplement, has ...

Treatment for depression could be revolutionised with new and more effective drug options thanks to a breakthrough involving ...

The world’s largest genetic study into depression has uncovered life-changing discoveries that will revolutionise treatments ...